Kristiina Kokkonen1, Tiina Tasmuth2, Juho T Lehto3, Hannu Kautiainen4, Anneli Elme2, Anna-Stina Jääskeläinen2, Tiina Saarto2. 1. Orton Oy and Faculty of Medicine, University of Helsinki, Helsinki, Finland Kristiina.kokkonen@helsinki.fi. 2. Helsinki University Hospital, Comprehensive Cancer Center, Department of Palliative Care and Faculty of Medicine, University of Helsinki, Helsinki, Finland. 3. Department of Oncology, Palliative Care Unit, Tampere University Hospital and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland. 4. Primary Health Care Unit, Finland and Folkhälsan Research Center, Kuopio University Hospital, Helsinki, Finland.
Abstract
BACKGROUND/AIM: To observe changes in symptoms and health-related quality of life (HRQoL) over 7 years among cancer patients at different stages of the disease. PATIENTS AND METHODS: This prospective cross-sectional study at the Helsinki University Hospital Cancer Center, was carried out in 2006 and repeated in 2013. All participants filled in the EORTC-QLQ-C30 questionnaire. RESULTS: Altogether, 581 patients responded (49% in 2006 and 54% in 2013). The disease was local in 51% and advanced in 49% of patients. The HRQoL was significantly lower, except for emotional and cognitive functions, and the symptom burden more severe in advanced cancer. The most prevalent symptoms were fatigue (93% and 85%; moderate/severe 22% and 9%), pain (65% and 47%; moderate/severe 16% and 5%), and insomnia (64% and 60%; moderate/severe 20 and 21%), respectively. No changes in HRQoL or symptoms were found at 7 years. CONCLUSION: There is a need for early integrated palliative care to improve HRQoL during cancer treatments. Copyright
BACKGROUND/AIM: To observe changes in symptoms and health-related quality of life (HRQoL) over 7 years among cancerpatients at different stages of the disease. PATIENTS AND METHODS: This prospective cross-sectional study at the Helsinki University Hospital Cancer Center, was carried out in 2006 and repeated in 2013. All participants filled in the EORTC-QLQ-C30 questionnaire. RESULTS: Altogether, 581 patients responded (49% in 2006 and 54% in 2013). The disease was local in 51% and advanced in 49% of patients. The HRQoL was significantly lower, except for emotional and cognitive functions, and the symptom burden more severe in advanced cancer. The most prevalent symptoms were fatigue (93% and 85%; moderate/severe 22% and 9%), pain (65% and 47%; moderate/severe 16% and 5%), and insomnia (64% and 60%; moderate/severe 20 and 21%), respectively. No changes in HRQoL or symptoms were found at 7 years. CONCLUSION: There is a need for early integrated palliative care to improve HRQoL during cancer treatments. Copyright
Authors: Caroline S Kampshoff; Irma M Verdonck-de Leeuw; Martijn G van Oijen; Mirjam A Sprangers; Laurien M Buffart Journal: Eur J Cancer Care (Engl) Date: 2019-05-14 Impact factor: 2.328
Authors: Frederic Bludau; Laura Winter; Grit Welzel; Udo Obertacke; Frank Schneider; Frederik Wenz; Arne Mathias Ruder; Frank A Giordano Journal: Radiat Oncol Date: 2020-11-12 Impact factor: 3.481
Authors: Hanh T H Nguyen; Khanh Linh Duong; Son T Nguyen; Quy Trinh; Hao T L Hoang; Toan Q Phung; Hsiang-Wen Lin; Huong T L Nguyen Journal: Cancer Manag Res Date: 2022-08-11 Impact factor: 3.602